SearchDictionaryMobileLogin

Kelly K Hunt Selected Research

Mastectomy (Mammectomy)

06/2005Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
12/2004Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
10/2004The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.
05/2004T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
09/2003Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy.
07/2002Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.

Articles by Research Topic

Disease

30Breast Neoplasms (Breast Cancer)
07/2008 - 01/2002
10Neoplasms (Cancer)
08/2008 - 07/2002
6Carcinoma (Carcinomatosis)
08/2005 - 05/2002
5Sarcoma (Soft Tissue Sarcoma)
10/2008 - 09/2002
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2007 - 12/2003
3Melanoma (Melanoma, Malignant)
05/2005 - 04/2002
3Noninfiltrating Intraductal Carcinoma (DCIS)
03/2004 - 11/2002
2Neoplasm Metastasis (Metastasis)
04/2008 - 04/2007
2Lung Neoplasms (Lung Cancer)
06/2003 - 04/2002
1Ductal Carcinoma
10/2007
1Residual Neoplasm
10/2006
1Leiomyosarcoma
11/2005
1Esophageal Neoplasms (Esophageal Cancer)
08/2005
1Hematologic Neoplasms (Hematological Malignancy)
11/2004
1Colonic Neoplasms (Colon Cancer)
04/2003

Drug/Important Bio-Agent (IBA)

4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008 - 08/2003
4eIF-2 Kinase (eIF 2 Kinase)IBA
11/2005 - 04/2002
3trastuzumab (Herceptin)FDA Link
01/2007 - 08/2004
3Paclitaxel (Taxol)FDA LinkGeneric
01/2007 - 06/2005
3imatinib (Gleevec)FDA Link
01/2007 - 12/2003
3Double-Stranded RNA (RNA, Double Stranded)IBA
08/2005 - 04/2002
2InterleukinsIBA
08/2008 - 02/2007
2Interleukin-10 (Interleukin 10)IBA
02/2007 - 05/2004
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2007 - 06/2005
2Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2iso-sulfan blue (Lymphazurin)FDA Link
08/2005 - 02/2004
1roscovitineIBA
10/2008
1AntigensIBA
07/2008
1CCAAT-Enhancer-Binding Protein-betaIBA
12/2007
1ElafinIBA
12/2007
1Radio-Opaque (Boston Post)IBA
12/2007
1interleukin-20 receptorIBA
02/2007
1Fluorouracil (Carac)FDA LinkGeneric
01/2007
1HormonesIBA
01/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007
1Vitamin D-Binding ProteinIBA
01/2006
1TANDEMIBA
01/2006
1celecoxib (Celebrex)FDA Link
09/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2005
1Cyclin EIBA
08/2005
1Technetium Tc 99m Sulfur ColloidFDA Link
01/2005
1Phosphotransferases (Kinase)IBA
09/2004
1Galactose OxidaseIBA
06/2004
1InterferonsIBA
06/2004
1TamoxifenFDA LinkGeneric
03/2004
1beta CateninIBA
08/2003
1Cytochromes c (Cytochrome c)IBA
06/2003
1Apoptosis Inducing FactorIBA
04/2003
1PeptidesIBA
05/2002

Therapy/Procedure

18Drug Therapy (Chemotherapy)
12/2007 - 04/2002
6Mastectomy (Mammectomy)
06/2005 - 07/2002
4Lymph Node Excision (Lymph Node Dissection)
07/2008 - 01/2002
4Segmental Mastectomy (Lumpectomy)
10/2007 - 11/2002
3Neoadjuvant Therapy
01/2008 - 06/2005
1Aftercare (After-Treatment)
01/2007
1Splenectomy
11/2004
1Mammaplasty (Breast Reconstruction)
02/2003
1Adjuvant Chemotherapy
07/2002